In vitro naive CD4 < sup > + < /sup > T cell differentiation upon treatment with miR-29b-loaded exosomes from mesenchymal stem cells
CONCLUSIONS: In conclusion, AMSC-Exo-based delivery of miR-29b can be considered as a new fascinating avenue for T cell differentiation inhibition and the future treatment of several inflammatory disorders.PMID:37725284 | DOI:10.1007/s11033-023-08767-w
Source: Mol Biol Cell - Category: Molecular Biology Authors: Zohreh Bolandi Seyed Mahmoud Hashemi Mozhgan Abasi Maryam Musavi Shahin Aghamiri Nastaran Miyanmahaleh Hossein Ghanbarian Source Type: research
More News: Arthritis | Genetics | Molecular Biology | Multiple Sclerosis | Rheumatoid Arthritis | Rheumatology | Stem Cell Therapy | Stem Cells | Study